Abstract | PURPOSE: MATERIALS AND METHODS: RESULTS: The study included 86 girls and 46 boys. There were no statistically significant differences among the 3 treatment groups regarding the presence of peripheral or central nervous system anticholinergic side effects. Extended release oxybutynin and long acting tolterodine were significantly more effective at reducing daytime urinary incontinence than immediate release tolterodine (p <0.01 and 0 <0.05, respectively). Extended release oxybutynin was significantly more effective then long acting tolterodine for complete resolution of diurnal incontinence (p <0.05). CONCLUSIONS:
|
Authors | Y Reinberg, J Crocker, J Wolpert, D Vandersteen |
Journal | The Journal of urology
(J Urol)
Vol. 169
Issue 1
Pg. 317-9
(Jan 2003)
ISSN: 0022-5347 [Print] United States |
PMID | 12478180
(Publication Type: Clinical Trial, Comparative Study, Journal Article)
|
Chemical References |
- Benzhydryl Compounds
- Cholinergic Antagonists
- Cresols
- Delayed-Action Preparations
- Dosage Forms
- Mandelic Acids
- Tartrates
- Phenylpropanolamine
- Tolterodine Tartrate
- oxybutynin
|
Topics |
- Adolescent
- Benzhydryl Compounds
(administration & dosage, adverse effects)
- Child
- Child, Preschool
- Cholinergic Antagonists
(administration & dosage, adverse effects)
- Cresols
(administration & dosage, adverse effects)
- Delayed-Action Preparations
- Dosage Forms
- Female
- Humans
- Male
- Mandelic Acids
(administration & dosage, adverse effects)
- Phenylpropanolamine
- Retrospective Studies
- Tartrates
(administration & dosage, adverse effects)
- Tolterodine Tartrate
- Urinary Incontinence
(drug therapy)
|